Skip to main content
  • ASM
    • Antimicrobial Agents and Chemotherapy
    • Applied and Environmental Microbiology
    • Clinical Microbiology Reviews
    • Clinical and Vaccine Immunology
    • EcoSal Plus
    • Eukaryotic Cell
    • Infection and Immunity
    • Journal of Bacteriology
    • Journal of Clinical Microbiology
    • Journal of Microbiology & Biology Education
    • Journal of Virology
    • mBio
    • Microbiology and Molecular Biology Reviews
    • Microbiology Resource Announcements
    • Microbiology Spectrum
    • Molecular and Cellular Biology
    • mSphere
    • mSystems
  • Log in
  • My alerts
  • My Cart

Main menu

  • Home
  • Articles
    • Current Issue
    • Accepted Manuscripts
    • COVID-19 Special Collection
    • Archive
    • Minireviews
  • For Authors
    • Submit a Manuscript
    • Scope
    • Editorial Policy
    • Submission, Review, & Publication Processes
    • Organization and Format
    • Errata, Author Corrections, Retractions
    • Illustrations and Tables
    • Nomenclature
    • Abbreviations and Conventions
    • Publication Fees
    • Ethics Resources and Policies
  • About the Journal
    • About AAC
    • Editor in Chief
    • Editorial Board
    • For Reviewers
    • For the Media
    • For Librarians
    • For Advertisers
    • Alerts
    • AAC Podcast
    • RSS
    • FAQ
  • Subscribe
    • Members
    • Institutions
  • ASM
    • Antimicrobial Agents and Chemotherapy
    • Applied and Environmental Microbiology
    • Clinical Microbiology Reviews
    • Clinical and Vaccine Immunology
    • EcoSal Plus
    • Eukaryotic Cell
    • Infection and Immunity
    • Journal of Bacteriology
    • Journal of Clinical Microbiology
    • Journal of Microbiology & Biology Education
    • Journal of Virology
    • mBio
    • Microbiology and Molecular Biology Reviews
    • Microbiology Resource Announcements
    • Microbiology Spectrum
    • Molecular and Cellular Biology
    • mSphere
    • mSystems

User menu

  • Log in
  • My alerts
  • My Cart

Search

  • Advanced search
Antimicrobial Agents and Chemotherapy
publisher-logosite-logo

Advanced Search

  • Home
  • Articles
    • Current Issue
    • Accepted Manuscripts
    • COVID-19 Special Collection
    • Archive
    • Minireviews
  • For Authors
    • Submit a Manuscript
    • Scope
    • Editorial Policy
    • Submission, Review, & Publication Processes
    • Organization and Format
    • Errata, Author Corrections, Retractions
    • Illustrations and Tables
    • Nomenclature
    • Abbreviations and Conventions
    • Publication Fees
    • Ethics Resources and Policies
  • About the Journal
    • About AAC
    • Editor in Chief
    • Editorial Board
    • For Reviewers
    • For the Media
    • For Librarians
    • For Advertisers
    • Alerts
    • AAC Podcast
    • RSS
    • FAQ
  • Subscribe
    • Members
    • Institutions
Susceptibility

Postantibiotic, Postantibiotic Sub-MIC, and Subinhibitory Effects of PGE-9509924, Ciprofloxacin, and Levofloxacin

Inga Odenholt, Elisabeth Löwdin, Otto Cars
Inga Odenholt
Antibiotic Research Unit, Department of Infectious Diseases and Clinical Microbiology, University Hospital, Uppsala, Sweden
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • For correspondence: inga.odenholt@inf.mas.lu.se
Elisabeth Löwdin
Antibiotic Research Unit, Department of Infectious Diseases and Clinical Microbiology, University Hospital, Uppsala, Sweden
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Otto Cars
Antibiotic Research Unit, Department of Infectious Diseases and Clinical Microbiology, University Hospital, Uppsala, Sweden
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
DOI: 10.1128/AAC.47.10.3352-3356.2003
  • Article
  • Figures & Data
  • Info & Metrics
  • PDF
Loading

Article Figures & Data

Tables

  • TABLE 1.

    MICs of PGE-9509924, levofloxacin, and ciprofloxacin for the various strains

    StrainMIC (mg/liter)
    PGE-9509924Levofloxacin by BioScreenCiprofloxacin by BioScreen
    MacrodilutionBioScreen
    S. pneumoniae ATCC 63060.030.0310.5
    S. pneumoniae R 21510.030.0610.5
    S. aureus ATCC 292130.030.030.250.25
    S. aureus Col. 18410.030.030.250.25
    S. aureus CCUG 356010.030.030.50.5
    E. coli ATCC 259220.1250.060.030.016
    K. pneumoniae ATCC 138830.50.1250.060.03
    P. aeruginosa ATCC 278532220.5
  • TABLE 2.

    PAEs of PGE-9509924, levofloxacin, and ciprofloxacin

    StrainPAEa (h)
    PGE-9509924Levofloxacin by BioScreenCiprofloxacin by BioScreen
    Viable countsBioScreen
    S. pneumoniae ATCC 63064.3 (4.0-4.4)6.8 (3.2-10.4)2.2 (2.0-2.3)1.2 (0.9-1.4)
    S. pneumoniae R21514.0 (3.6-4.3)6.9 (6.6-7.2)1.7 (1.3-2.0)0.4 (0.3-0.4)
    S. aureus ATCC 292132.3 (1.8-3.0)2.6 (2.0-3.2)2.2 (2.0-2.3)0.6 (0.3-0.8)
    S. aureus Col. 18416.7 (4.6-9.0)1.1 (0.3-1.9)1.3 (1.2-1.3)2.1 (1.1-3.1)
    S. aureus CCUG 356013.8 (2.3-6.0)0.3 (0-0.6)1.2 (0.6-1.8)2.3 (1.4-3.1)
    E. coli ATCC 259223.7 (2.8-4.5)2.3 (2.1-2.4)2.8 (2.4-3.2)2.5 (2.4-2.6)
    K. pneumoniae ATCC 138832.2 (2-2.3)0.9 (0.9-0.9)0.7 (0.5-0.9)0.7 (0.4-0.9)
    P. aeruginosa ATCC 278530.9 (0.5-1.4)0.1 (−0.9-1.0)0.1 (−0.2-0.4)0.6 (0.5-0.6)
    • ↵ a Values are means of two experiments, with ranges in parentheses.

  • TABLE 3.

    PA SMEs of PGE-9509924, levofloxacin, and ciprofloxacin

    StrainPA SMEa (h) at indicated multiple of the MIC
    PGE-9509924LevofloxacinCiprofloxacin
    0.10.20.30.10.20.30.10.20.3
    S. pneumoniae ATCC 630611.4 (4.7-18.1)12.4 (6.6-18.1)15.9 (13.7-18.1)3.0 (2.9-3.0)4.4 (3.3-5.4)19.6 (19.2-20)1.9 (1.7-2.1)4.0 (4.0-4.0)7.3 (7.1-7.5)
    S. pneumoniae R 21518.7 (8.1-9.3)11.5 (11-12)13.2 (12.14.4)3.2 (3.0-3.3)7.8 (5.4-10.1)13.2 (10.9-15.4)1.3 (1.0-1.5)3.4 (2.4-4.4)7.0 (4.6-9.4)
    S. aureus ATCC 292134.5 (4.1-4.9)14.3 (11.2-17.4)18.3 (18.1-18.5)2.8 (2.4-3.1)5.8 (5.6-5.9)14.4 (8.8-19.9)1.0 (0.6-1.3)2.3 (1.4-3.1)5.3 (2.0-8.5)
    S. aureus Col. 18412.8 (2.4-3.1)5.0 (4.0-5.9)11.3 (7.1-15.5)1.8 (1.4-2.2)2.9 (2.4-3.4)4.7 (3.0-6.3)2.6 (1.1-4.0)6.2 (1.1-11.2)10.3 (1.8-18.8)
    S. aureus CCUG 356012.0 (1.4-2.5)6.0 (5.1-6.9)17.0 (16.6-17.3)2.0 (1.3-2.6)17.6 (17.6-17.6)17.6 (17.6-17.6)3.6 (3.0-4.2)18.5 (18.1-18.9)18.5 (18.1-18.4)
    E. coli ATCC 259222.8 (2.6-3.0)7.7 (4.3-11.1)12.2 (4.9-19.4)3.3 (2.8-3.7)4.2 (3.4-4.9)14.2 (7.3-21.1)3.1 (2.5-3.6)6.2 (4.4-7.9)20.2 (19.4-21)
    K. pneumoniae ATCC 138831.9 (1.9-1.9)4.4 (4.4-4.4)12.8 (9.4-16.1)1.5 (1.2-1.8)4.0 (3.2-4.8)9.6 (6.9-12.2)1.1 (0.6-1.5)2.9 (2.9-2.9)6.7 (6.5-6.9)
    P. aeruginosa ATCC 278531.1 (0.6-1.6)7.5 (7.5-7.5)14.6 (14.0-15.1)1.1 (0.8-1.4)2.8 (2.2-3.3)6.4 (5.6-7.1)2.5 (2.0-3.0)10.5 (9.4-11.5)14.0 (13.6-14.4)
    • ↵ a Values are means of two experiments, with ranges in parentheses.

  • TABLE 4.

    SMEs of PGE-9509924, levofloxacin, and ciprofloxacin

    StrainSMEa (h) at indicated multiple of the MIC
    PGE-9509924LevofloxacinCiprofloxacin
    0.10.20.30.10.20.30.10.20.3
    S. pneumoniae ATCC 63061.1 (0.6-1.6)6.5 (2.4-10.5)12.0 (5.3-18.6)0.4 (0.3-0.4)2.7 (2.3-3.1)8.3 (7.5-9.0)0.5 (0.5-0.5)1.9 (1.8-2.0)5.6 (4.6-6.5)
    S. pneumoniae R21512.2 (2.0-2.4)4.8 (3.0-6.6)8.7 (3.8-13.6)1.3 (1.0-1.6)5.6 (3.1-8.0)10.8 (5.9-15.6)0.8 (0.3-1.3)3.3 (1.9-4.9)8.9 (3.8-14.0)
    S. aureus ATCC 292131.3 (0.6-1.9)7.4 (2.8-12.0)15.8 (13.5-18.0)0.3 (2.4-3.1)1.3 (5.6-5.9)9.9 (8.8-19.9)0 (0-0)0.5 (0.3-0.6)1.0 (0.8-1.1)
    S. aureus Col. 1840.8 (0.6-0.9)1.9 (1.3-2.5)3.6 (2.8-4.4)0.2 (0-0.3)1.0 (0.9-1.1)1.4 (1.1-1.6)0 (0-0)0.1 (0-0.2)0.3 (0-0.5)
    S. aureus CCUG 356010.9 (1.4-2.5)2.0 (5.1-6.9)8.9 (16.6-17.3)0.6 (1.3-2.6)10.5 (17.6-17.6)18.7 (17.6-17.6)0.7 (3.0-4.2)9.7 (18.1-18.9)18.3 (18.1-18.4)
    E. coli ATCC 259220 (0-0)0.2 (0-0.3)1.0 (0.5-1.4)0.1 (0-0.1)0.4 (0.3-0.4)1.2 (0.8-1.6)0.3 (0.3-0.3)1.2 (0.8-1.6)13 (5-21)
    K. pneumoniae ATCC 138830.4 (0.3-0.4)2.4 (1.9-2.9)13.4 (10.6-16.1)0.2 (0-0.3)2.0 (1.3-2.6)9.4 (8.8-10.0)0.5 (0.4-0.6)1.9 (1.9-1.9)6.4 (6.3-6.4)
    P. aeruginosa ATCC 278530.9 (0.4-1.3)9.9 (6.4-13.3)14.4 (13.3-15.4)0.6 (0.3-0.9)2.3 (2.0-2.5)4.0 (2.9-5.0)1.0 (0-1.9)8.4 (4.0-12.8)13.4 (12.8-14.0)
    • ↵ a Values are means of two experiments, with ranges in parentheses.

PreviousNext
Back to top
Download PDF
Citation Tools
Postantibiotic, Postantibiotic Sub-MIC, and Subinhibitory Effects of PGE-9509924, Ciprofloxacin, and Levofloxacin
Inga Odenholt, Elisabeth Löwdin, Otto Cars
Antimicrobial Agents and Chemotherapy Sep 2003, 47 (10) 3352-3356; DOI: 10.1128/AAC.47.10.3352-3356.2003

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Print

Alerts
Sign In to Email Alerts with your Email Address
Email

Thank you for sharing this Antimicrobial Agents and Chemotherapy article.

NOTE: We request your email address only to inform the recipient that it was you who recommended this article, and that it is not junk mail. We do not retain these email addresses.

Enter multiple addresses on separate lines or separate them with commas.
Postantibiotic, Postantibiotic Sub-MIC, and Subinhibitory Effects of PGE-9509924, Ciprofloxacin, and Levofloxacin
(Your Name) has forwarded a page to you from Antimicrobial Agents and Chemotherapy
(Your Name) thought you would be interested in this article in Antimicrobial Agents and Chemotherapy.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Share
Postantibiotic, Postantibiotic Sub-MIC, and Subinhibitory Effects of PGE-9509924, Ciprofloxacin, and Levofloxacin
Inga Odenholt, Elisabeth Löwdin, Otto Cars
Antimicrobial Agents and Chemotherapy Sep 2003, 47 (10) 3352-3356; DOI: 10.1128/AAC.47.10.3352-3356.2003
del.icio.us logo Digg logo Reddit logo Twitter logo CiteULike logo Facebook logo Google logo Mendeley logo
  • Top
  • Article
    • ABSTRACT
    • FOOTNOTES
    • REFERENCES
  • Figures & Data
  • Info & Metrics
  • PDF

KEYWORDS

anti-infective agents
ciprofloxacin
levofloxacin
ofloxacin
quinolones

Related Articles

Cited By...

About

  • About AAC
  • Editor in Chief
  • Editorial Board
  • Policies
  • For Reviewers
  • For the Media
  • For Librarians
  • For Advertisers
  • Alerts
  • AAC Podcast
  • RSS
  • FAQ
  • Permissions
  • Journal Announcements

Authors

  • ASM Author Center
  • Submit a Manuscript
  • Article Types
  • Ethics
  • Contact Us

Follow #AACJournal

@ASMicrobiology

       

ASM Journals

ASM journals are the most prominent publications in the field, delivering up-to-date and authoritative coverage of both basic and clinical microbiology.

About ASM | Contact Us | Press Room

 

ASM is a member of

Scientific Society Publisher Alliance

 

American Society for Microbiology
1752 N St. NW
Washington, DC 20036
Phone: (202) 737-3600

Copyright © 2021 American Society for Microbiology | Privacy Policy | Website feedback

Print ISSN: 0066-4804; Online ISSN: 1098-6596